2-Bromo-LSD
From WikiMD's WELLNESSPEDIA
What is 2-Bromo-LSD?[edit]
- It is a serotonin 5-HT2A receptor antagonist[1].
- It blocks the effects of LSD [2],4 but has no psychological effects on its own[3].
- IUPAC Name: (6aR,9R)-5-bromo-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- InChI: InChI=1S/C20H24BrN3O/c1-4-24(5-2)20(25)12-9-14-13-7-6-8-16-18(13)15(19(21)22-16)10-17(14)23(3)11-12/h6-9,12,17,22H,4-5,10-11H2,1-3H3/t12-,17-/m1/s1
- InChI Key: VKRAXSZEDRWLAG-SJKOYZFVSA-N
- Canonical SMILES: CCN(CC)C(=O)C1CN(C2CC3=C(NC4=CC=CC(=C34)C2=C1)Br)C
- Isomeric SMILES: CCN(CC)C(=O)[C@H]1CN([C@@H]2CC3=C(NC4=CC=CC(=C34)C2=C1)Br)C
- Molecular formula: C20H24BrN3O
- Molecular weight: 402.3 g·mol−1
- PubChem CID: 10171
- Synonyms:
- BROMOLYSERGIDE
- 2-Bromolysergic acid diethylamide
- 478-84-2
- UNII-JUA77QEU32
- JUA77QEU32
- CHEMBL274384
- Ergoline-8-carboxamide, 2-bromo-9,10-didehydro-N,N-diethyl-6-methyl-, (8beta)-
- Bromlysergamide
- BOL-148
- Bromolysergic acid diethylamide
- D-2-Bromolysergic acid diethylamide
- 2-Bromo-D-lysergic acid diethylamide
- Brom LSD
- 2-Br-LSD
- USAF SZ-1
- 2-Brom-D-lysergic acid diethylamine
- LSD,2-Bromo
- D-2-Brom-diethylamide of lysergic acid
- GTPL272
- SCHEMBL1883414
- DTXSID30878496
- BDBM50130269
- ZINC13531276
- 2-Bromo-9,10-didehydro-N,N-diethyl-6-methylergoline-8-beta-carboxamide
- 9,10-Didehydro-N,N-diethyl-2-bromo-6-methylergoline-8-beta-carboxamide
- Ergoline-8-beta-carboxamide, 2-bromo-9,10-didehydro-N,N-diethyl-6-methyl-
- Q4596865
- (6aR,9R)-5-Bromo-7-methyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid diethylamide
- (6aR,9R)-5-bromo-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- 5-Bromo-7-methyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid diethylamide
References[edit]
- ↑ Nichols DE. Structure–activity relationships of serotonin 5-HT2A agonists. Wiley Interdisciplinary Reviews: Membrane Transport and Signaling. 2012;1(5):559-579. doi:10.1002/wmts.42
- ↑ Ginzel KH, Mayer-Gross W. Prevention of Psychological Effects of d -Lysergic Acid Diethylamide (LSD 25) by its 2-Brom Derivative (BOL 148). Nature. 1956;178(4526):210-210. doi:10.1038/178210a0
- ↑ Cerletti A, Rothlin E. Role of 5-Hydroxytryptamine in Mental Diseases and its Antagonism to Lysergic Acid Derivatives. Nature. 1955;176(4486):785-786. doi:10.1038/176785a0
- ↑ National Center for Biotechnology Information (2021). PubChem Compound Summary for CID 10171, Bromolysergide. Retrieved August 14, 2021 from [1].
| Antimigraine preparations (N02C) | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Serotonin receptor modulators | ||||||
|---|---|---|---|---|---|---|
|
